Work

Abstract 5074: Optimizing erlotinib plus sulindac dosing regimens in a preclinical model of FAP

Year: 2019

Type: conference-abstract

Source: Prevention, Early Detection, and Interception

DOI: 10.1158/1538-7445.sabcs18-5074

Authors: Ahmetmursel Ulusan, Praveen Rajendran, Wan-Mohaiza Dashwood, Altaf Mohammed, Shizuko Sei, Powel H. Brown, Eduardo Vilar-Sanchez, Roderick H. Dashwood

Institutions: Texas A&M University, National Cancer Institute, The University of Texas MD Anderson Cancer Center

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4240647620

Cites:

Cited by: 3

Related to: 10